Metformin: A Hopeful Promise in Aging Research
Open accessThe DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
Even though the inevitable process of aging by itself cannot be considered a disease, it is directly linked to life span and is the driving force behind all age-related diseases. It is an undisputable fact that age-associated diseases are among the leading causes of death in the world, primarily in industrialized countries. During the last several years, an intensive search of antiaging treatments has led to the discovery of a variety of drugs that promote health span and/or life extension. The biguanide compound metformin is widely used for treating people with type 2 diabetes and appears to show protection against cancer, inflammation, and age-related pathologies. Here, we summarize the recent developments about metformin use in translational aging research and discuss its role as a potential geroprotector.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The antidiabetic drug metformin, which, among other activities, inhibits the SASP, alleviates several age-related conditions and chronic diseases110–114.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [110]
In the citing paper
“Metformin, resveratrol and rapalogs (agents related to rapamycin) are SASP inhibitors and appear to impact some of the same basic processes as caloric restriction or exercise110,138.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [110]
In the citing paper
“Metformin has now been found to target several age-related pathways(3, 276, 277)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [277]
Citations
Cites
1 retracted
Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo
Zou, M.-H., Kirkpatrick, S. S., Davis, B. J., Nelson, J. S., Wiles, W. G., Schlattner, U., Neumann, D., Brownlee, M., Freeman, M. B., & Goldman, M. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404421200 · Cited by 478
RetractedStandards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 3×
“The role of LKB1– AMPK as mediator of metformin’s action on hepatic gluconeogenesis and lipogenesis (Zhou et al. 2001; Zou et al. 2004; Shaw et al. 2005) was put to test in studies using conditional Ampk knockout mice (Foretz et al.”
BackgroundAMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · cited 4×
“In the latter study, metformin-mediated mGPD inhibition was accompanied by lower mitochondrial NADH/NADþ ratios, a result inconsistent with prior reports showing that complex I inhibition by metformin increased this ratio (Owen et al. 2000).”
BackgroundResultInfluentialThe Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, E., Shyy, J. Y.-J., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.009 · Cited by 1,778
Bailey, C. J., & Turner, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602293340906 · Cited by 1,726
mTOR is a key modulator of ageing and age-related disease
Johnson, S. C., Rabinovitch, P. S., & Kaeberlein, M. (2013) · Nature · doi:10.1038/nature11861 · Cited by 1,676 · cited 1×
“Because of the many faces of mTOR in life span and metabolism, it is intriguing that metformin may act as a potential therapeutic drug for the treatment of aging and age-related diseases, such as cancer and metabolic syndrome (Johnson et al. 2013).”
BackgroundKinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
Metformin: from mechanisms of action to therapies
Foretz, M., Guigas, B., Bertrand, L., Pollak, M., & Viollet, B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.018 · Cited by 1,501
Standards of Medical Care in Diabetes 2014
(2014) · Majmaah Journal of Health Sciences · doi:10.12816/0004790 · Cited by 1,465
Metformin improves healthspan and lifespan in mice
Martin-Montalvo, A., Mercken, E. M., Mitchell, S. J., Palacios, H. H., Mote, P. L., Scheibye-Knudsen, M., Gomes, A. P., Ward, T. M., Minor, R. K., Blouin, M.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms3192 · Cited by 1,445
Self-citationEl-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399 · cited 1×
“The decrease in cellular respiration that results from metformin’s inhibition of mitochondrial complex I activity (El-Mir et al. 2000; Owen et al. 2000) yields lower ATP levels.”
BackgroundMetformin—mode of action and clinical implications for diabetes and cancer
Pernicova, I., & Korbonits, M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.256 · Cited by 1,349
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Madiraju, A. K., Erion, D. M., Rahimi, Y., Zhang, X.-M., Braddock, D. T., Albright, R. A., Prigaro, B. J., Wood, J. L., Bhanot, S., MacDonald, M. J., et al. (2014) · Nature · doi:10.1038/nature13270 · Cited by 1,284 · cited 2×
“2013), and direct inhibition of mitochondrial glycerophosphate dehydrogenase (mGPD) (Madiraju et al. 2014).”
BackgroundSchulz, T. J., Zarse, K., Voigt, A., Urban, N., Birringer, M., & Ristow, M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.011 · Cited by 1,209 · cited 2×
“Conversely, glucose restriction extends C. elegans life span by inducing mitohormesis, a physiological process based on mitochondrial oxidative stress (Schulz et al. 2007; Zarse et al. 2012).”
BackgroundForetz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181 · cited 3×
“2005) was put to test in studies using conditional Ampk knockout mice (Foretz et al. 2010).”
BackgroundMethodPearson, K. J., Baur, J. A., Lewis, K. N., Peshkin, L., Price, N. L., Labinskyy, N., Swindell, W. R., Kamara, D., Minor, R. K., Perez, E., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.011 · Cited by 1,162
Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span
Selman, C., Tullet, J. M. A., Wieser, D., Irvine, E., Lingard, S. J., Choudhury, A. I., Claret, M., Al-Qassab, H., Carmignac, D., Ramadani, F., et al. (2009) · Science · doi:10.1126/science.1177221 · Cited by 1,120 · cited 1×
“%) without changes in that of male animals (Selman et al. 2009).”
BackgroundThe CREB coactivator TORC2 is a key regulator of fasting glucose metabolism
Koo, S.-H., Flechner, L., Qi, L., Zhang, X., Screaton, R. A., Jeffries, S., Hedrick, S., Xu, W., Boussouar, F., Brindle, P., et al. (2005) · Nature · doi:10.1038/nature03967 · Cited by 995
Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism
Cabreiro, F., Au, C., Leung, K.-Y., Vergara-Irigaray, N., Cochemé, H. M., Noori, T., Weinkove, D., Schuster, E., Greene, N. D. E., & Gems, D. (2013) · Cell · doi:10.1016/j.cell.2013.02.035 · Cited by 967 · cited 2×
“A number of recent studies support the role of metformin in improving health span and life span in different animal models (Anisimov et al. 2011; Cabreiro et al. 2013; Martin-Montalvo et al. 2013; Anisimov 2014; De Haes et al. 2014).”
BackgroundResultDowling, R. J. O., Zakikhani, M., Fantus, I. G., Pollak, M., & Sonenberg, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2310 · Cited by 933
Fullerton, M. D., Galic, S., Marcinko, K., Sikkema, S., Pulinilkunnil, T., Chen, Z.-P., O'Neill, H. M., Ford, R. J., Palanivel, R., O'Brien, M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3372 · Cited by 893
Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner
Kalender, A., Selvaraj, A., Kim, S. Y., Gulati, P., Brûlé, S., Viollet, B., Kemp, B. E., Bardeesy, N., Dennis, P., Schlager, J. J., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.014 · Cited by 889 · cited 2×
“Inhibition of the Ras-related GTP binding (Rag) GTPases (Kalender et al. 2010) and up-regulation of REDD1, a hypoxiainducible factor 1 (HIF-1) target (Shoshani et al. 2002; Ben Sahra et al. 2011), are among the AMPK-independent mechanisms by which metformin inhibits mTORC1 signaling.”
BackgroundHypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH
Zhang, G., Li, J., Purkayastha, S., Tang, Y., Zhang, H., Yin, Y., Li, B., Liu, G., & Cai, D. (2013) · Nature · doi:10.1038/nature12143 · Cited by 834 · cited 1×
“Many aspects of aging are controlled by the hypothalamus, and alteration of hypothalamic pathways might allow the manifestations of aging to be modified (Zhang et al. 2013).”
BackgroundBiguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
Miller, R. A., Chu, Q., Xie, J., Foretz, M., Viollet, B., & Birnbaum, M. J. (2013) · Nature · doi:10.1038/nature11808 · Cited by 833
Hawley, S. A., Gadalla, A. E., Olsen, G. S., & Hardie, D. G. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2420 · Cited by 696
Onken, B., & Driscoll, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008758 · Cited by 671 · cited 2×
“This increase in health span had CR-like features that involved activation of the LKB1–AMPK–SKN1 pathway both in wild-type worms and in mutant animals with disrupted insulin pathway (Onken and Driscoll 2010).”
BackgroundRole of AMP-activated protein kinase in mechanism of metformin action
Zhou, G., Myers, R., Li, Y., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113505 · Cited by 635
Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1
Ben Sahra, I., Regazzetti, C., Robert, G., Laurent, K., Le Marchand-Brustel, Y., Auberger, P., Tanti, J.-F., Giorgetti-Peraldi, S., & Bost, F. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1769 · Cited by 616
Identification of a Novel Hypoxia-Inducible Factor 1-Responsive Gene, RTP801 , Involved in Apoptosis
Shoshani, T., Faerman, A., Mett, I., Zelin, E., Tenne, T., Gorodin, S., Moshel, Y., Elbaz, S., Budanov, A., Chajut, A., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2283-2293.2002 · Cited by 546
Mitochondria—A Nexus for Aging, Calorie Restriction, and Sirtuins?
Guarente, L. (2008) · Cell · doi:10.1016/j.cell.2008.01.007 · Cited by 513
Metformin Inhibits Proinflammatory Responses and Nuclear Factor-κB in Human Vascular Wall Cells
Isoda, K., Young, J. L., Zirlik, A., MacFarlane, L. A., Tsuboi, N., Gerdes, N., Schönbeck, U., & Libby, P. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000201938.78044.75 · Cited by 499
Metformin pathways: pharmacokinetics and pharmacodynamics
Gong, L., Goswami, S., Giacomini, K. M., Altman, R. B., & Klein, T. E. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283559b22 · Cited by 495
Hirsch, H. A., Iliopoulos, D., & Struhl, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221055110 · Cited by 440 · cited 2×
“2012); it may also influence metabolic and cellular processes associated with the development of chronic conditions of aging, including inflammation, fatty liver, oxidative damage, protein glycation, cellular senescence, diminished autophagy, apoptosis, and development of several types of cancer (Isoda et al. 2006; Ki…”
BackgroundZarse, K., Schmeisser, S., Groth, M., Priebe, S., Beuster, G., Kuhlow, D., Guthke, R., Platzer, M., Kahn, C. R., & Ristow, M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.02.013 · Cited by 430 · cited 2×
“Conversely, glucose restriction extends C. elegans life span by inducing mitohormesis, a physiological process based on mitochondrial oxidative stress (Schulz et al. 2007; Zarse et al. 2012).”
BackgroundKim, Y. D., Park, K.-G., Lee, Y.-S., Park, Y.-Y., Kim, D.-K., Nedumaran, B., Jang, W. G., Cho, W.-J., Ha, J., Lee, I.-K., et al. (2008) · Diabetes · doi:10.2337/db07-0381 · Cited by 422
Anisimov, V. N., Berstein, L. M., Egormin, P. A., Piskunova, T. S., Popovich, I. G., Zabezhinski, M. A., Kovalenko, I. G., Poroshina, T. E., Semenchenko, A. V., Provinciali, M., et al. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.07.007 · Cited by 402
Hong, J., Zhang, Y., Lai, S., Lv, A., Su, Q., Dong, Y., Zhou, Z., Tang, W., Zhao, J., Cui, L., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0719 · Cited by 366 · cited 2×
“There is some evidence that metformin may also have cardioprotective effects (Eurich et al. 2013; Hong et al. 2013) and contribute to the prevention of some forms of human cancer (Cazzaniga et al.”
BackgroundMetformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2
De Haes, W., Frooninckx, L., Van Assche, R., Smolders, A., Depuydt, G., Billen, J., Braeckman, B. P., Schoofs, L., & Temmerman, L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321776111 · Cited by 355 · cited 3×
“A number of recent studies support the role of metformin in improving health span and life span in different animal models (Anisimov et al. 2011; Cabreiro et al. 2013; Martin-Montalvo et al. 2013; Anisimov 2014; De Haes et al. 2014).”
BackgroundResultMetformin slows down aging and extends life span of female SHR mice
Anisimov, V. N., Berstein, L. M., Egormin, P. A., Piskunova, T. S., Popovich, I. G., Zabezhinski, M. A., Tyndyk, M. L., Yurova, M. V., Kovalenko, I. G., Poroshina, T. E., et al. (2008) · Cell Cycle · doi:10.4161/cc.7.17.6625 · Cited by 348
The Search for Antiaging Interventions: From Elixirs to Fasting Regimens
de Cabo, R., Carmona-Gutierrez, D., Bernier, M., Hall, M. N., & Madeo, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.031 · Cited by 345 · cited 2×
“These investigators reported similar gene expression patterns in the liver (and skeletal muscle) of mice fed 40% CR and 0.1% metformin, reinforcing the role of metformin as a CR mimetic (Mercken et al. 2012; de Cabo et al. 2014).”
BackgroundSelf-citationEurich, D. T., Weir, D. L., Majumdar, S. R., Tsuyuki, R. T., Johnson, J. A., Tjosvold, L., Vanderloo, S. E., & McAlister, F. A. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.000162 · Cited by 341
Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes
Ng, T. P., Feng, L., Yap, K. B., Lee, T. S., Tan, C. H., & Winblad, B. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131901 · Cited by 334
Lessons from C. elegans: signaling pathways for longevity
Lapierre, L. R., & Hansen, M. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.07.007 · Cited by 331
Of mice and men: the benefits of caloric restriction, exercise, and mimetics
Mercken, E. M., Carboneau, B. A., Krzysik-Walker, S. M., & de Cabo, R. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2011.11.005 · Cited by 318
Maida, A., Lamont, B. J., Cao, X., & Drucker, D. J. (2011) · Diabetologia · doi:10.1007/s00125-010-1937-z · Cited by 294
Stephenne, X., Foretz, M., Taleux, N., van der Zon, G. C., Sokal, E., Hue, L., Viollet, B., & Guigas, B. (2011) · Diabetologia · doi:10.1007/s00125-011-2311-5 · Cited by 287 · cited 2×
“The increase in AMP/ATP and ADP/ ATP ratios stimulates AMPK (Stephenne et al. 2011); however, metformin can activate AMPK without eliciting detectable changes in AMP, ADP, and ATP levels (Hawley et al.”
BackgroundAnisimov, V. N., Berstein, L. M., Popovich, I. G., Zabezhinski, M. A., Egormin, P. A., Piskunova, T. S., Semenchenko, A. V., Tyndyk, M. L., Yurova, M. N., Kovalenko, I. G., et al. (2011) · Aging · doi:10.18632/aging.100273 · Cited by 285 · cited 2×
“A number of recent studies support the role of metformin in improving health span and life span in different animal models (Anisimov et al. 2011; Cabreiro et al. 2013; Martin-Montalvo et al. 2013; Anisimov 2014; De Haes et al. 2014).”
BackgroundResultBatandier, C., Guigas, B., Detaille, D., El-Mir, M., Fontaine, E., Rigoulet, M., & Leverve, X. M. (2006) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-006-9003-8 · Cited by 279
Diamanti-Kandarakis, E., Christakou, C. D., Kandaraki, E., & Economou, F. N. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0733 · Cited by 247
Gunton, J. E., Delhanty, P. J. D., Takahashi, S.-I., & Baxter, R. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021394 · Cited by 234
Metformin therapy in a transgenic mouse model of Huntington's disease
Ma, T. C., Buescher, J. L., Oatis, B., Funk, J. A., Nash, A. J., Carrier, R. L., & Hoyt, K. R. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.10.039 · Cited by 222
Metformin and cancer: Doses, mechanisms and the dandelion and hormetic phenomena
Martin-Castillo, B., Vazquez-Martin, A., Oliveras-Ferraros, C., & Menendez, J. A. (2010) · Cell Cycle · doi:10.4161/cc.9.6.10994 · Cited by 212
Slack, C., Foley, A., & Partridge, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047699 · Cited by 199
Woo, S.-L., Xu, H., Li, H., Zhao, Y., Hu, X., Zhao, J., Guo, X., Guo, T., Botchlett, R., Qi, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091111 · Cited by 194
Worms need microbes too: microbiota, health and aging in Caenorhabditis elegans
Cabreiro, F., & Gems, D. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201100972 · Cited by 193
Stenesen, D., Suh, J. M., Seo, J., Yu, K., Lee, K.-S., Kim, J.-S., Min, K.-J., & Graff, J. M. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.006 · Cited by 192
Glueck, C. J., Fontaine, R. N., Wang, P., Subbiah, M. T. R., Weber, K., Illig, E., Streicher, P., Sieve-Smith, L., Tracy, T. M., Lang, J. E., et al. (2001) · Metabolism · doi:10.1053/meta.2001.24192 · Cited by 188 · cited 2×
“Food intake (Adeyemo et al. 2014; Pernicova and Korbonits 2014) and body weight (Glueck et al. 2001) are decreased as a result of a direct action of metformin on the hypothalamic centers regulating satiety and feeding (Stevanovic et al. 2012); it may also influence metabolic and cellular processes…”
BackgroundCao, J., Meng, S., Chang, E., Beckwith-Fickas, K., Xiong, L., Cole, R. N., Radovick, S., Wondisford, F. E., & He, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.567271 · Cited by 169
Diabetes drugs and neurological disorders: new views and therapeutic possibilities
Patrone, C., Eriksson, O., & Lindholm, D. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70125-6 · Cited by 161
Yin, M., Zhou, J., Gorak, E. J., & Quddus, F. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0111 · Cited by 157
Collier, C. A., Bruce, C. R., Smith, A. C., Lopaschuk, G., & Dyck, D. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00272.2005 · Cited by 154
Metformin Supplementation and Life Span in Fischer-344 Rats
Smith, D. L., Elam, C. F., Mattison, J. A., Lane, M. A., Roth, G. S., Ingram, D. K., & Allison, D. B. (2010) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glq033 · Cited by 153
Kita, Y., Takamura, T., Misu, H., Ota, T., Kurita, S., Takeshita, Y., Uno, M., Matsuzawa-Nagata, N., Kato, K.-I., Ando, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043056 · Cited by 152
Meng, S., Cao, J., He, Q., Xiong, L., Chang, E., Radovick, S., Wondisford, F. E., & He, L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.604421 · Cited by 146 · cited 2×
“When therapeutic concentrations of metformin were tested, hepatic gluconeogenesis was suppressed via AMPK activation (Cao et al. 2014) and formation of AMPK abg complexes (Meng et al. 2014).”
BackgroundAnisimov, V. N., Egormin, P. A., Piskunova, T. S., Popovich, I. G., Tyndyk, M. L., Yurova, M. N., Zabezhinski, M. A., Anikin, I. V., Karkach, A. S., & Romanyukha, A. A. (2010) · Cell Cycle · doi:10.4161/cc.9.1.10407 · Cited by 146
Survival of Patients with Stage IV Lung Cancer with Diabetes Treated with Metformin
Lin, J. J., Gallagher, E. J., Sigel, K., Mhango, G., Galsky, M. D., Smith, C. B., LeRoith, D., & Wisnivesky, J. P. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201407-1395oc · Cited by 137
Metformin Pharmacogenomics: Current Status and Future Directions
Pawlyk, A. C., Giacomini, K. M., McKeon, C., Shuldiner, A. R., & Florez, J. C. (2014) · Diabetes · doi:10.2337/db13-1367 · Cited by 136
Anisimov, V. N., Piskunova, T. S., Popovich, I. G., Zabezhinski, M. A., Tyndyk, M. L., Egormin, P. A., Yurova, M. N., Rosenfeld, S. V., Semenchenko, A. V., Kovalenko, I. G., et al. (2010) · Aging · doi:10.18632/aging.100245 · Cited by 126
Identification of potential caloric restriction mimetics by microarray profiling
Dhahbi, J. M., Mote, P. L., Fahy, G. M., & Spindler, S. R. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00069.2005 · Cited by 122
Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice
Choi, C.-I., Lee, Y.-D., Gwag, B. J., Cho, S. I., Kim, S.-S., & Suh-Kim, H. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.10.024 · Cited by 118
Using Caenorhabditis elegans as a Model for Aging and Age‐Related Diseases
OLSEN, A., VANTIPALLI, M. C., & LITHGOW, G. J. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1354.015 · Cited by 117
Metformin Decelerates Aging and Development of Mammary Tumors in HER-2/neu Transgenic Mice
Anisimov, V. N., Egormin, P. A., Берштейн, Л. М., Zabezhinskiĭ, M. A., Piskunova, T. S., Popovich, I. G., & Semenchenko, A. V. (2005) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-005-0389-9 · Cited by 109
Cellular Responses to the Metal-Binding Properties of Metformin
Logie, L., Harthill, J., Patel, K., Bacon, S., Hamilton, D. L., Macrae, K., McDougall, G., Wang, H.-H., Xue, L., Jiang, H., et al. (2012) · Diabetes · doi:10.2337/db11-0961 · Cited by 108
Laskov, I., Drudi, L. M., Beauchamp, M.-C., Yasmeen, A., Ferenczy, A. S., Pollak, M., & Gotlieb, W. H. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.06.014 · Cited by 104
Lenaerts, I., Walker, G. A., Van Hoorebeke, L., Gems, D., & Vanfleteren, J. R. (2008) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/63.3.242 · Cited by 94
Effects of metformin on head and neck cancer: A systematic review
Rêgo, D. F., Pavan, L. M. C., Elias, S. T., Canto, G. D. L., & Guerra, E. N. S. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2015.01.007 · Cited by 91
New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser
Cho, Y. M., & Kieffer, T. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1986-3 · Cited by 91
Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells
Li, W., Yuan, Y., Huang, L., Qiao, M.-M., & Zhang, Y. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.12.028 · Cited by 91
Metformin Inhibits Aromatase via an Extracellular Signal-Regulated Kinase-Mediated Pathway
Rice, S., Pellatt, L., Ramanathan, K., Whitehead, S. A., & Mason, H. D. (2009) · Endocrinology · doi:10.1210/en.2009-0540 · Cited by 88
Metformin: The hidden chronicles of a magic drug
Mahmood, K., Naeem, M., & Rahimnajjad, N. A. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2012.10.011 · Cited by 87
Kaneb, H. M., Sharp, P. S., Rahmani-Kondori, N., & Wells, D. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024189 · Cited by 86
Metformin in obesity, cancer and aging: addressing controversies
Berstein, L. M. (2012) · Aging · doi:10.18632/aging.100455 · Cited by 85
The effect of metformin on apoptosis in a breast cancer presurgical trial
Cazzaniga, M., DeCensi, A., Pruneri, G., Puntoni, M., Bottiglieri, L., Varricchio, C., Guerrieri-Gonzaga, A., Gentilini, O. D., Pagani, G., Dell'Orto, P., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.657 · Cited by 81
Improving survival with metformin: the evidence base today
Scarpello, J. H. B. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(03)72786-4 · Cited by 78
Control of Gluconeogenesis by Metformin: Does Redox Trump Energy Charge?
Baur, J. A., & Birnbaum, M. J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.013 · Cited by 73
Wang, C., Lorenzo, C., & Espinoza, S. E. (2014) · PubMed · Cited by 69
Na, H., Park, J., Pyo, J.-H., Lee, S., Jeon, H.-J., Kim, Y.-S., & Yoo, M. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.07.003 · Cited by 66
Metformin enhances glucagon-like peptide 1 via cooperation between insulin and Wnt signaling
Kim, M.-H., Jee, J.-H., Park, S., Lee, M.-S., Kim, K.-W., & Lee, M.-K. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0381 · Cited by 66
Effects of metformin on energy intake and satiety in obese children
Adeyemo, M. A., McDuffie, J. R., Kozlosky, M., Krakoff, J., Calis, K. A., Brady, S. M., & Yanovski, J. A. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12426 · Cited by 61
Gerosuppressant Metformin: less is more
Menendez, J. A., Cufí, S., Oliveras-Ferraros, C., Vellon, L., Joven, J., & Vazquez-Martin, A. (2011) · Aging · doi:10.18632/aging.100316 · Cited by 58
Anisimov, V. N., Popovich, I. G., Zabezhinski, M. A., Egormin, P. A., Yurova, M. N., Semenchenko, A. V., Tyndyk, M. L., Panchenko, A. V., Trashkov, A. P., Vasiliev, A. G., et al. (2015) · Cell Cycle · doi:10.4161/15384101.2014.973308 · Cited by 55
microRNAs and cancer metabolism reprogramming: the paradigm of metformin.
Pulito, C., Donzelli, S., Muti, P. C., Puzzo, L., Strano, S., & Blandino, G. (2014) · PubMed · doi:10.3978/j.issn.2305-5839.2014.06.03 · Cited by 54
Use of microarray biomarkers to identify longevity therapeutics
Spindler, S. R. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00194.x · Cited by 52
Stevanovic, D., Janjetovic, K., Misirkic, M., Vucicevic, L., Sumarac-Dumanovic, M., Micic, D., Starcevic, V., & Trajkovic, V. (2012) · Neuroendocrinology · doi:10.1159/000333963 · Cited by 51
Big mice die young but large animals live longer
Blagosklonny, M. V. (2013) · Aging · doi:10.18632/aging.100551 · Cited by 50
Metformin and the risk of endometrial cancer: A population-based cohort study
Ko, E. M., Stürmer, T., Hong, J., Castillo, W. C., Bae-Jump, V. L., & Funk, M. J. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.12.001 · Cited by 50
Pharmacogenetic Variation and Metformin Response
Chen, S., Zhou, J., Xi, M., Jia, Y., Wong, Y., Zhao, J., Ding, L., Zhang, J., & Wen, A. (2013) · Current Drug Metabolism · doi:10.2174/1389200214666131211153933 · Cited by 50
Tohyama, D., & Yamaguchi, A. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.126 · Cited by 45
Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery
Aldea, M. D., Craciun, L., Tomuleasa, C., Berindan‐Neagoe, I., Kacsó, G., Florian, I. Ş., & Crivii, C. B. (2014) · Tumor Biology · doi:10.1007/s13277-014-1676-8 · Cited by 44
LaRue, B. L., & Padilla, P. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016790 · Cited by 43
Pioglitazone: an anti-diabetic compound with anti-aging properties
Jafari, M., Khodayari, B., Felgner, J., Bussel, I. I., Rose, M. R., & Mueller, L. D. (2007) · Biogerontology · doi:10.1007/s10522-007-9105-7 · Cited by 41
Bulterijs, S. (2011) · Rejuvenation Research · doi:10.1089/rej.2011.1153 · Cited by 39
Cancer and aging: More puzzles, more promises?
Blagosklonny, M. V., & Campisi, J. (2008) · Cell Cycle · doi:10.4161/cc.7.17.6626 · Cited by 36
Use of Metformin in Diseases of Aging
Miles, J. M., Rule, A. D., & Borlaug, B. A. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0490-4 · Cited by 34
Do metformin a real anticarcinogen? A critical reappraisal of experimental data.
Anisimov, V. N. (2014) · PubMed · doi:10.3978/j.issn.2305-5839.2014.06.02 · Cited by 32
Metformin improves survival and recurrence rate in patients with diabetes and gastric cancer
Greenhill, C. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.9 · Cited by 32
Metformin and respiratory chain complex I: the last piece of the puzzle?
Fontaine, E. M. (2014) · Biochemical Journal · doi:10.1042/bj20141020 · Cited by 31
Yuan, L., Ziegler, R., & Hamann, A. (2003) · PubMed · Cited by 22
Effects of Neonatal Programming on Hypothalamic Mechanisms Controlling Energy Balance
Contreras, C., Novelle, M. G., Leis, R., Diéguez, C., Skrede, S., & López, M. (2013) · Hormone and Metabolic Research · doi:10.1055/s-0033-1351281 · Cited by 19
Self-citationAnisimov, V. N., Zabezhinski, M. A., Popovich, I. G., Pliss, G. B., Беспалов, В. Г., Alexandrov, V. A., Стуков, А. Н., Anikin, I. V., Alimova, I. N., Egormin, P. A., et al. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.642361 · Cited by 13
Metformin and the risk of endometrial cancer: A population-based cohort study
Ko, E. M., Stürmer, T., Hong, J.-P., Camelo, W., Bae-Jump, V. L., & Funk, M. J. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.03.099 · Cited by 8
The effect of metformin on apoptosis in a breast cancer presurgical trial
Sandulache, V. C., & Skinner, H. D. (2014) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2014.04.026 · Cited by 6
Cited by
Cellular senescence and senolytics: the path to the clinic
Chaib, S., Tchkonia, T., & Kirkland, J. L. (2022) · Nature Medicine · doi:10.1038/s41591-022-01923-y · Cited by 1,134
Benefits of Metformin in Attenuating the Hallmarks of Aging
Kulkarni, A. S., Gubbi, S., & Barzilai, N. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.001 · Cited by 766
Metformin limits osteoarthritis development and progression through activation of AMPK signalling
Li, J., Zhang, B., Liu, W.-X., Lu, K., Pan, H., Wang, T., Oh, C.-D., Yi, D., Huang, J., Zhao, L., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216713 · Cited by 300
Making sense of the ageing methylome
Seale, K., Horvath, S., Teschendorff, A., Eynon, N., & Voisin, S. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00477-6 · Cited by 274
Metformin as Anti-Aging Therapy: Is It for Everyone?
Soukas, A. A., Hao, H., & Wu, L. (2019) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2019.07.015 · Cited by 263
Metadata
- Authors
- Novelle, M. G., Ali, A., Diéguez, C., Bernier, M., & de Cabo, R.
- Affiliations
- National Institutes of Health (US)
- Centro de Investigación Biomédica en Red (ES)
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-03
- Volume
- 6
- Issue
- 3
- Pages
- a025932
- ISSN
- 2157-1422 (ISSN-L)
- PMC
- PMC4772077
- OpenAlex
- W2289120809
- Cited by
- 178
- References
- 116
- Citations by year
- 2026: 17 · 2025: 13 · 2024: 27 · 2023: 16 · 2022: 23 · 2021: 21 · 2020: 24 · 2019: 12 · 2018: 12 · 2017: 11 · 2016: 2
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- U.S. Food and Drug Administration
- Instituto de Salud Carlos III
- National Institute on Aging
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- metformin, aging, age-related diseases, healthspan, lifespan extension, type 2 diabetes, cancer protection, inflammation
- MeSH terms
- Aging, Humans, Life Expectancy, Metformin, Translational Research, Biomedical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.